Polsky Bruce
Reporting owner on Forms 3, 4 and 5, CIK 1508458.
Polsky Bruce reported on 1 issuer in 2 filings, the latest a Form 4 filed 2026-11-19.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| AVIR · Atea Pharmaceuticals, Inc.CIK 1593899 | director | 2 | 2026-11-19 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| AVIR · Atea Pharmaceuticals, Inc.Common Stock | 2026-11-19 | S sold | -8,750 | $4.0341 | 149,830 | Form 4 |
| AVIR · Atea Pharmaceuticals, Inc.Common Stock | 2026-11-18 | M exercised | +18,252 | $1.24 | 176,832 | Form 4 |
| AVIR · Atea Pharmaceuticals, Inc.Common Stock | 2026-11-18 | S sold | -18,252 | $3.9502 | 158,580 | Form 4 |
| AVIR · Atea Pharmaceuticals, Inc.Stock Option (Right to Buy), derivative | 2026-11-18 | M exercised | -18,252 | $0 | 0 | Form 4 |
| AVIR · Atea Pharmaceuticals, Inc.Common Stock | 2026-11-17 | M exercised | +8,720 | $1.24 | 167,300 | Form 4 |
| AVIR · Atea Pharmaceuticals, Inc.Common Stock | 2026-11-17 | S sold | -8,720 | $4.0316 | 158,580 | Form 4 |
| AVIR · Atea Pharmaceuticals, Inc.Stock Option (Right to Buy), derivative | 2026-11-17 | M exercised | -8,720 | $0 | 18,252 | Form 4 |
| AVIR · Atea Pharmaceuticals, Inc.Common Stock | 2026-11-16 | M exercised | +48,028 | $1.24 | 172,834 | Form 4 |
| AVIR · Atea Pharmaceuticals, Inc.Common Stock | 2026-11-16 | S sold | -14,254 | $4.2683 | 158,580 | Form 4 |
| AVIR · Atea Pharmaceuticals, Inc.Stock Option (Right to Buy), derivative | 2026-11-16 | M exercised | -48,028 | $0 | 26,972 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001193125-26-469037 | Atea Pharmaceuticals, Inc. | 2026-11-19 | ||
| Form 4 0001193125-26-467490 | Atea Pharmaceuticals, Inc. | 2026-11-18 |